nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.356	1	CbGbCtD
Cefadroxil—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00169	0.00262	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00168	0.00262	CcSEcCtD
Cefadroxil—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.0026	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00167	0.0026	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.0026	CcSEcCtD
Cefadroxil—Blood bilirubin increased—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00259	CcSEcCtD
Cefadroxil—Creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00257	CcSEcCtD
Cefadroxil—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00257	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00165	0.00256	CcSEcCtD
Cefadroxil—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00163	0.00253	CcSEcCtD
Cefadroxil—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00163	0.00253	CcSEcCtD
Cefadroxil—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00163	0.00253	CcSEcCtD
Cefadroxil—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00161	0.00251	CcSEcCtD
Cefadroxil—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.00251	CcSEcCtD
Cefadroxil—Blood urea increased—Epirubicin—peripheral nervous system neoplasm	0.00161	0.0025	CcSEcCtD
Cefadroxil—Vaginal infection—Epirubicin—peripheral nervous system neoplasm	0.00161	0.0025	CcSEcCtD
Cefadroxil—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00249	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.0016	0.00248	CcSEcCtD
Cefadroxil—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00159	0.00248	CcSEcCtD
Cefadroxil—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00159	0.00247	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00246	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00246	CcSEcCtD
Cefadroxil—Phosphatase alkaline increased—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00245	CcSEcCtD
Cefadroxil—Vaginal inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00245	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00156	0.00243	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00151	0.00235	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00233	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00233	CcSEcCtD
Cefadroxil—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00231	CcSEcCtD
Cefadroxil—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00231	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.0023	CcSEcCtD
Cefadroxil—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00229	CcSEcCtD
Cefadroxil—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00147	0.00229	CcSEcCtD
Cefadroxil—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00147	0.00228	CcSEcCtD
Cefadroxil—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00228	CcSEcCtD
Cefadroxil—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00146	0.00227	CcSEcCtD
Cefadroxil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00146	0.00227	CcSEcCtD
Cefadroxil—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00226	CcSEcCtD
Cefadroxil—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00226	CcSEcCtD
Cefadroxil—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00225	CcSEcCtD
Cefadroxil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00225	CcSEcCtD
Cefadroxil—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00225	CcSEcCtD
Cefadroxil—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00225	CcSEcCtD
Cefadroxil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00225	CcSEcCtD
Cefadroxil—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00144	0.00224	CcSEcCtD
Cefadroxil—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00144	0.00223	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00221	CcSEcCtD
Cefadroxil—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00142	0.00221	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00142	0.0022	CcSEcCtD
Cefadroxil—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.0014	0.00217	CcSEcCtD
Cefadroxil—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00216	CcSEcCtD
Cefadroxil—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00214	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00137	0.00212	CcSEcCtD
Cefadroxil—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00136	0.00212	CcSEcCtD
Cefadroxil—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00211	CcSEcCtD
Cefadroxil—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00135	0.0021	CcSEcCtD
Cefadroxil—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.0021	CcSEcCtD
Cefadroxil—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00134	0.00208	CcSEcCtD
Cefadroxil—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00133	0.00207	CcSEcCtD
Cefadroxil—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00133	0.00206	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00205	CcSEcCtD
Cefadroxil—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00204	CcSEcCtD
Cefadroxil—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00204	CcSEcCtD
Cefadroxil—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00131	0.00204	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00204	CcSEcCtD
Cefadroxil—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00131	0.00203	CcSEcCtD
Cefadroxil—Asthenia—Melphalan—peripheral nervous system neoplasm	0.0013	0.00202	CcSEcCtD
Cefadroxil—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00202	CcSEcCtD
Cefadroxil—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00202	CcSEcCtD
Cefadroxil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00128	0.00199	CcSEcCtD
Cefadroxil—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00128	0.00199	CcSEcCtD
Cefadroxil—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00198	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00197	CcSEcCtD
Cefadroxil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00126	0.00197	CcSEcCtD
Cefadroxil—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00195	CcSEcCtD
Cefadroxil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00195	CcSEcCtD
Cefadroxil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00195	CcSEcCtD
Cefadroxil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00124	0.00192	CcSEcCtD
Cefadroxil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00192	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.0019	CcSEcCtD
Cefadroxil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.0019	CcSEcCtD
Cefadroxil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00122	0.0019	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00122	0.0019	CcSEcCtD
Cefadroxil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00188	CcSEcCtD
Cefadroxil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00188	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00186	CcSEcCtD
Cefadroxil—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00119	0.00186	CcSEcCtD
Cefadroxil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00184	CcSEcCtD
Cefadroxil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.00184	CcSEcCtD
Cefadroxil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00184	CcSEcCtD
Cefadroxil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00118	0.00183	CcSEcCtD
Cefadroxil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00181	CcSEcCtD
Cefadroxil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00181	CcSEcCtD
Cefadroxil—Rash—Topotecan—peripheral nervous system neoplasm	0.00117	0.00181	CcSEcCtD
Cefadroxil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00116	0.00181	CcSEcCtD
Cefadroxil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00116	0.0018	CcSEcCtD
Cefadroxil—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00116	0.0018	CcSEcCtD
Cefadroxil—Headache—Topotecan—peripheral nervous system neoplasm	0.00116	0.0018	CcSEcCtD
Cefadroxil—Rash—Tretinoin—peripheral nervous system neoplasm	0.00116	0.0018	CcSEcCtD
Cefadroxil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.0018	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00116	0.0018	CcSEcCtD
Cefadroxil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00179	CcSEcCtD
Cefadroxil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00179	CcSEcCtD
Cefadroxil—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00115	0.00179	CcSEcCtD
Cefadroxil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00115	0.00179	CcSEcCtD
Cefadroxil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00179	CcSEcCtD
Cefadroxil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00179	CcSEcCtD
Cefadroxil—Rash—Melphalan—peripheral nervous system neoplasm	0.00114	0.00177	CcSEcCtD
Cefadroxil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00114	0.00177	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00177	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00173	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00173	CcSEcCtD
Cefadroxil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00172	CcSEcCtD
Cefadroxil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00172	CcSEcCtD
Cefadroxil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00171	CcSEcCtD
Cefadroxil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00171	CcSEcCtD
Cefadroxil—Nausea—Topotecan—peripheral nervous system neoplasm	0.0011	0.00171	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.0011	0.0017	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00109	0.0017	CcSEcCtD
Cefadroxil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00169	CcSEcCtD
Cefadroxil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00169	CcSEcCtD
Cefadroxil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00108	0.00169	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00168	CcSEcCtD
Cefadroxil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00108	0.00167	CcSEcCtD
Cefadroxil—Nausea—Melphalan—peripheral nervous system neoplasm	0.00108	0.00167	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00167	CcSEcCtD
Cefadroxil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00106	0.00165	CcSEcCtD
Cefadroxil—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00165	CcSEcCtD
Cefadroxil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00106	0.00164	CcSEcCtD
Cefadroxil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00106	0.00164	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.0016	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.0016	CcSEcCtD
Cefadroxil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.00159	CcSEcCtD
Cefadroxil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00159	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00159	CcSEcCtD
Cefadroxil—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00158	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00157	CcSEcCtD
Cefadroxil—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.001	0.00155	CcSEcCtD
Cefadroxil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000997	0.00155	CcSEcCtD
Cefadroxil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000987	0.00153	CcSEcCtD
Cefadroxil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000983	0.00153	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00098	0.00152	CcSEcCtD
Cefadroxil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000964	0.0015	CcSEcCtD
Cefadroxil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000961	0.00149	CcSEcCtD
Cefadroxil—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000954	0.00148	CcSEcCtD
Cefadroxil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000953	0.00148	CcSEcCtD
Cefadroxil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000951	0.00148	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000945	0.00147	CcSEcCtD
Cefadroxil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000945	0.00147	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00094	0.00146	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000937	0.00146	CcSEcCtD
Cefadroxil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000936	0.00145	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000925	0.00144	CcSEcCtD
Cefadroxil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000919	0.00143	CcSEcCtD
Cefadroxil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000916	0.00142	CcSEcCtD
Cefadroxil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00089	0.00138	CcSEcCtD
Cefadroxil—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00089	0.00138	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000887	0.00138	CcSEcCtD
Cefadroxil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000886	0.00138	CcSEcCtD
Cefadroxil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000884	0.00137	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000882	0.00137	CcSEcCtD
Cefadroxil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000876	0.00136	CcSEcCtD
Cefadroxil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000876	0.00136	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000875	0.00136	CcSEcCtD
Cefadroxil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000872	0.00136	CcSEcCtD
Cefadroxil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000871	0.00135	CcSEcCtD
Cefadroxil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000862	0.00134	CcSEcCtD
Cefadroxil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00086	0.00134	CcSEcCtD
Cefadroxil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000858	0.00133	CcSEcCtD
Cefadroxil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000858	0.00133	CcSEcCtD
Cefadroxil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00133	CcSEcCtD
Cefadroxil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000852	0.00132	CcSEcCtD
Cefadroxil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00085	0.00132	CcSEcCtD
Cefadroxil—Rash—Vincristine—peripheral nervous system neoplasm	0.000844	0.00131	CcSEcCtD
Cefadroxil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000844	0.00131	CcSEcCtD
Cefadroxil—Headache—Vincristine—peripheral nervous system neoplasm	0.000839	0.0013	CcSEcCtD
Cefadroxil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000826	0.00128	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000823	0.00128	CcSEcCtD
Cefadroxil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00081	0.00126	CcSEcCtD
Cefadroxil—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000809	0.00126	CcSEcCtD
Cefadroxil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000799	0.00124	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.00124	CcSEcCtD
Cefadroxil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000795	0.00124	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.00123	CcSEcCtD
Cefadroxil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000778	0.00121	CcSEcCtD
Cefadroxil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000768	0.00119	CcSEcCtD
Cefadroxil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000753	0.00117	CcSEcCtD
Cefadroxil—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000749	0.00116	CcSEcCtD
Cefadroxil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000747	0.00116	CcSEcCtD
Cefadroxil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000746	0.00116	CcSEcCtD
Cefadroxil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000742	0.00115	CcSEcCtD
Cefadroxil—Tension—Epirubicin—peripheral nervous system neoplasm	0.000731	0.00114	CcSEcCtD
Cefadroxil—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000724	0.00112	CcSEcCtD
Cefadroxil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000717	0.00111	CcSEcCtD
Cefadroxil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000716	0.00111	CcSEcCtD
Cefadroxil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000703	0.00109	CcSEcCtD
Cefadroxil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00069	0.00107	CcSEcCtD
Cefadroxil—Rash—Etoposide—peripheral nervous system neoplasm	0.000684	0.00106	CcSEcCtD
Cefadroxil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000683	0.00106	CcSEcCtD
Cefadroxil—Headache—Etoposide—peripheral nervous system neoplasm	0.00068	0.00106	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000677	0.00105	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00067	0.00104	CcSEcCtD
Cefadroxil—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000669	0.00104	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.00103	CcSEcCtD
Cefadroxil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000646	0.001	CcSEcCtD
Cefadroxil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000644	0.001	CcSEcCtD
Cefadroxil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000986	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.000962	CcSEcCtD
Cefadroxil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000945	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000928	CcSEcCtD
Cefadroxil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000925	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000587	0.000912	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000874	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000861	CcSEcCtD
Cefadroxil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.000856	CcSEcCtD
Cefadroxil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000541	0.00084	CcSEcCtD
Cefadroxil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000535	0.000832	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000816	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000797	CcSEcCtD
Cefadroxil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.000777	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000773	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.00077	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000755	CcSEcCtD
Cefadroxil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000483	0.000751	CcSEcCtD
Cefadroxil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000747	CcSEcCtD
Cefadroxil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000747	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000715	CcSEcCtD
Cefadroxil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000696	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000447	0.000695	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000691	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000691	CcSEcCtD
Cefadroxil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000678	CcSEcCtD
Cefadroxil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00043	0.000668	CcSEcCtD
Cefadroxil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000646	CcSEcCtD
Cefadroxil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000644	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000627	CcSEcCtD
Cefadroxil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000625	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000619	CcSEcCtD
Cefadroxil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000601	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000598	CcSEcCtD
Cefadroxil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000596	CcSEcCtD
Cefadroxil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000595	CcSEcCtD
Cefadroxil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000592	CcSEcCtD
Cefadroxil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000578	CcSEcCtD
Cefadroxil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000561	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000556	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000551	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000551	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000548	CcSEcCtD
Cefadroxil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000519	CcSEcCtD
